Related Experiment Video
Updated: Nov 11, 2025
09:22
Chronic Thromboembolic Pulmonary Hypertension and Assessment of Right Ventricular Function in the Piglet
Published on: November 4, 2015
12.4K
Giant pulmonary hydatid cyst in children
Alaa Aqqad1, Besma Hamdi1, Sabrine Louhaichi1
1Department B, Abderrahmen Mami Hospital, 2080 Ariana, Tunisia.
Summary
Giant hydatid cysts (GHC) in children require major surgery, often involving parenchymal resection. Early diagnosis and treatment are crucial for managing these lung conditions.
Area of Science:
- Pediatric Surgery
- Thoracic Surgery
- Parasitology
Background:
- Pulmonary hydatid cyst (PHC) is a significant parasitic infection.
- Giant hydatid cysts (GHC) represent a distinct clinical entity in pediatric lungs due to tissue elasticity.
- The lungs are the second most common site for hydatid disease.
Purpose of the Study:
- To compare clinical and imaging features of GHC versus non-giant pulmonary hydatid cysts (NGHC) in children.
- To evaluate surgical interventions and postoperative outcomes for pediatric pulmonary hydatid cysts.
- To identify differences in management and complications between GHC and NGHC.
Main Methods:
- Retrospective analysis of pediatric pulmonary hydatid cyst cases from 2004-2019.
- Classification of cysts into GHC (≥10cm) and NGHC (<10cm).
- Comparison of clinical presentation, surgical procedures, and complications between GHC and NGHC groups.
Main Results:
- Giant hydatid cysts (GHC) constituted 19.4% of pediatric pulmonary hydatid cysts (PHC).
- Parenchymal resection was significantly more common in GHC (50%) compared to NGHC (18.8%).
- No significant differences in postoperative complications or recurrence were observed between GHC and NGHC groups.
Conclusions:
- Giant hydatid cysts (GHC) in children are a unique clinical entity requiring specialized surgical approaches.
- Major surgery, including parenchymal resection, is often necessary for GHC management.
- Prompt diagnosis and therapeutic intervention are essential for optimal outcomes in pediatric GHC.
Related Concept Videos
01:28Pulmonary Tuberculosis II
821
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
821
01:23Cystic Fibrosis: Pathogenesis
531
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
531
01:27Pneumothorax-II
577
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
577
01:29Pulmonary Tuberculosis I
472
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
472
01:24Cystic Fibrosis: Management
305
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
305
01:17Gross Anatomy of the Lungs
3.2K
The lungs are a pair of vital organs connected to the trachea via the left and right bronchi. The base of these organs meets the dome-shaped muscle known as the diaphragm. Encased by the pleurae, the lungs contact the mediastinum. The right lung is shorter yet wider, and has a larger volume than the left lung. The left lung has an indentation known as the cardiac notch. The superior region of the lungs is referred to as the apex, whereas the base is the lower region near the diaphragm. The...
3.2K